QI
AMRX icon

Qtron Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Qtron Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,945
Closed -$37.5K – 403
2023
Q1 		$37.5K Buy
+26,945
New +$53.6K 0.01% 408
2021
Q3 		– Sell
-10,861
Closed -$56K – 300
2021
Q2 		$56K Buy
+10,861
New +$61.7K 0.01% 338

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Qtron Investments's AMRX Position: Q2 2023 in Review

Qtron Investments sold out of Amneal Pharmaceuticals (AMRX) in Q2 2023, closing a stake of 26,945 shares — an estimated $37.5K sold.

Qtron Investments first reported a position in AMRX in Q2 2021 and held it in 2 quarters. The position peaked at $56K in Q2 2021. 128 funds tracked by Wall St. Rank hold AMRX as of Q2 2023.

  • Qtron Investments reported no remaining Amneal Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Qtron Investments sold 26,945 Amneal Pharmaceuticals shares in Q2 2023, an estimated $37.5K.
  • Qtron Investments first reported a position in Amneal Pharmaceuticals in Q2 2021 and held it in 2 quarters.
  • Qtron Investments's Amneal Pharmaceuticals position peaked at $56K in Q2 2021.
  • 128 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2023.

Based on Qtron Investments's 13F filing for Q2 2023, filed 10 Aug 2023.